David Fabrizio
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
- Lung Cancer Research Studies
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 57
- Cancer Immunotherapy and Biomarkers 37
- Colorectal Cancer Treatments and Studies 9
- Lung Cancer Research Studies 5
-
- Cancer Genomics and Diagnostics 55
- Co-authors
- Garrett M. Frampton (39 shared papers)Siraj M. Ali (26 shared papers)Jeffrey S. Ross (30 shared papers)Alexa B. Schrock (27 shared papers)Vincent A. Miller (27 shared papers)Samuel J. Klempner (7 shared papers)Kyle Gowen (5 shared papers)Philip J. Stephens (16 shared papers)
- Journals
- Journal of Clinical Oncology (23 papers)Annals of Oncology (14 papers)Cancer Research (7 papers)npj Precision Oncology (4 papers)The Oncologist (4 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
David Fabrizio
85 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 86
- Oncology 1.6k
- Cancer Research 731
- Pulmonary and Respiratory Medicine 794
- Pathology and Forensic Medicine 399
- Immunology 364
Countries citing papers authored by David Fabrizio
This map shows the geographic impact of David Fabrizio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Fabrizio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Fabrizio more than expected).
Fields of papers citing papers by David Fabrizio
This network shows the impact of papers produced by David Fabrizio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Fabrizio. The network helps show where David Fabrizio may publish in the future.
Co-authors
The 25 scholars most cited alongside David Fabrizio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 253 | |
| 2 | 2018 | 205 | |
| 3 | 2018 | 194 | |
| 4 | 2005 | 193 | |
| 5 | 2019 | 168 | |
| 6 | 2018 | 157 | |
| 7 | 2016 | 150 | |
| 8 | 2021 | 140 | |
| 9 | 2019 | 128 | |
| 10 | 2022 | 116 | |
| 11 | 2020 | 106 | |
| 12 | 2004 | 95 | |
| 13 | 2017 | 87 | |
| 14 | 2022 | 86 | |
| 15 | 2023 | 84 | |
| 16 | 2017 | 65 | |
| 17 | 2020 | 56 | |
| 18 | 2018 | 45 | |
| 19 | 2017 | 44 | |
| 20 | 2019 | 41 |
About David Fabrizio
David Fabrizio is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Molecular Biology, having authored 89 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (55 papers), Cancer Immunotherapy and Biomarkers (37 papers), Lung Cancer Treatments and Mutations (30 papers), Genetic factors in colorectal cancer (11 papers), Colorectal Cancer Treatments and Studies (9 papers), Ferroptosis and cancer prognosis (6 papers), Prostate Cancer Treatment and Research (5 papers) and Lung Cancer Research Studies (5 papers). The work is most often cited by research in Oncology (1.6k citations), Cancer Research (731 citations), Pulmonary and Respiratory Medicine (794 citations), Pathology and Forensic Medicine (399 citations) and Immunology (364 citations). David Fabrizio has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Garrett M. Frampton, Siraj M. Ali, Jeffrey S. Ross, Alexa B. Schrock, Vincent A. Miller, Samuel J. Klempner, Kyle Gowen, Philip J. Stephens, Aaron M. Goodman and James Sun. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, npj Precision Oncology and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.